Arsani William, Director at Design Therapeutics, Inc. (DSGN), bought 50,000 shares at $18.99 ($950K) on 2022-03-21, disclosed to the SEC on 2022-03-22.
Open-market purchase of $950k DSGN by Director. Below the thresholds we flag for high-conviction alerts (no C-suite role, rare reversal, cluster, or A-grade history). Context: insider career grade D.
Nothing distinguishes this filing.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $18.99 | 25,000 | $475K | 50.0% |
| 2 | $18.99 | 25,000 | $475K | 50.0% |
| Total | $18.99 avg | 50,000 | $950K | 100% |
| Filing → |
| DSGN | BUY | 2023-08-30 | $5.4M | — | Filing → |
| DSGN | BUY | 2021-09-02 | $618K | — | Filing → |
| DSGN | BUY | 2021-04-01 | $14.0M | — | Filing → |